INTERNATIONAL PATENT: VACCINEX, INC. FILES APPLICATION FOR "USE OF SEMAPHORIN-4D INHIBITORY MOLECULES TO TREAT COGNITIVE IMPAIRMENT"

GENEVA, Feb. 11 -- VACCINEX, INC. (1895 Mt. Hope AvenueRochester, New York 14620) filed a patent application (PCT/US2025/039651) for "USE OF SEMAPHORIN-4D INHIBITORY MOLECULES TO TREAT COGNITIVE IMPAIRMENT" on Jul 29, 2025. With publication no. WO/2026/030311, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZAUDERER, Maurice (44 Woodland RoadPittsford, New York 14534), EVANS, Elizabeth E. (41 Main StreetBloomfield, New York 14469)

Abstract: The disclosure relates to methods for treating cognitive decline or selecting sub...